BloombergSen Inc. Reduces Stake in HCA Healthcare, Inc. $HCA

BloombergSen Inc. decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 255,918 shares of the company’s stock after selling 19,807 shares during the quarter. HCA Healthcare comprises about 8.7% of BloombergSen Inc.’s investment portfolio, making the stock its 4th biggest holding. BloombergSen Inc. owned about 0.11% of HCA Healthcare worth $119,478,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. MJP Associates Inc. ADV raised its stake in HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after buying an additional 21 shares during the last quarter. Sovran Advisors LLC raised its stake in shares of HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares during the last quarter. Centerpoint Advisors LLC raised its stake in shares of HCA Healthcare by 11.0% in the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares during the last quarter. Cary Street Partners Financial LLC raised its stake in shares of HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares during the last quarter. Finally, Plato Investment Management Ltd raised its stake in shares of HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.5%

NYSE HCA opened at $394.40 on Friday. The firm has a market cap of $87.49 billion, a price-to-earnings ratio of 13.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18. The business has a 50-day moving average price of $465.16 and a 200-day moving average price of $483.61. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the company earned $6.45 EPS. The business’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Wall Street Analyst Weigh In

Several analysts recently commented on HCA shares. Argus cut their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Wells Fargo & Company cut their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a report on Monday, April 27th. Weiss Ratings lowered HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday. Oppenheimer cut their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, KeyCorp cut their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $515.77.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.